register

News & Trends - Pharmaceuticals

Cancer care network ‘to address existing disparities in cancer outcomes’, says Health Minister

Health Industry Hub | May 21, 2024 |

Pharma News: Announced by the government at the Innovations Showcase event, hosted by Cancer Australia in Sydney, the launch of the Australian Comprehensive Cancer Network (ACCN) aims to improve cancer outcomes and experiences for all Australians.

Mark Butler MP, Federal Minister for Health, underscored the pivotal role of the ACCN, stating, “The ACCN represents a crucial step forward in ensuring that every Australian, regardless of their background or location, receives the best possible cancer care. By linking services, fostering collaboration and sharing expertise, the ACCN aims to address existing disparities in cancer outcomes, particularly among rural and Indigenous populations.”

Encouraging broad participation, Minister Butler emphasised, “All services and professionals involved in cancer care are encouraged to join the ACCN and contribute to this transformative initiative. Together, we can make substantial strides in improving cancer outcomes and experiences for all Australians.”

Despite Australia’s commendable global standing in cancer survival rates, persistent disparities persist, notably affecting rural and remote communities, culturally and linguistically diverse (CALD) patients, as well as Aboriginal and Torres Strait Islander populations.

Professor Dorothy Keefe, CEO of Cancer Australia, highlighted the ACCN’s role in advancing the objectives set forth in the Australian Cancer Plan, asserting, “To achieve world class cancer outcomes for all Australians and realise the ambition of the Australian Cancer Plan, we need collective action from all sectors of health care to address issues that contribute to variation in cancer outcomes and experience.”

The ACCN does not aim to duplicate existing networks or alliances within and between jurisdictions that deliver cancer care or conduct cancer research and clinical trials. At the core of the ACCN are the Comprehensive Cancer Centres (CCCs), which will serve as linchpins in connecting cancer services nationwide.

Through strategic partnerships and leveraging virtual connectivity, CCCs will collaborate with various stakeholders, including academic institutions, Aboriginal Community Controlled Health Services, regional hospitals, and allied health services to share expertise and access to comprehensive cancer care for all people affected by cancer.  

Participation in the ACCN is voluntary, potentially leading to a lower uptake initially. For services that decide to partner, there will be an impact evaluation in the context of the broader Australian Cancer Plan after 2, 5 and 10 years.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


News & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer

AI-powered test to reshape use of hormone therapy in prostate cancer

Health Industry Hub | February 6, 2025 |

Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]

More


News & Trends - MedTech & Diagnostics

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Vantive debuts as standalone business amid complex landscape of chronic kidney disease

Health Industry Hub | February 6, 2025 |

Vantive, formerly Baxter’s Kidney Care business, has officially launched as a standalone company. The move follows Baxter’s completion of the […]

More


News & Trends - MedTech & Diagnostics

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Optalert unveils test for sleep apnoea as Philips expands partnership in pharmacy program

Health Industry Hub | February 6, 2025 |

An Australian medical technology company has introduced a test designed to identify obstructive sleep apnoea (OSA), broadening access to sleep […]

More


This content is copyright protected. Please subscribe to gain access.